2002

Nov 15, 2002
Guidant to Highlight New Advances in Heart Failure Management During 75th Scientific Sessions of the American Heart Association

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it is providing support for a special Continuing...

Nov 15, 2002
Guidant Appoints Joseph M. Smith, M.D., Ph.D. as Chief Medical Officer for Cardiac Rhythm Management

Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Joseph M. Smith, M.D., Ph.D....

Nov 14, 2002
New National Registry Will Study Left Ventricular Dysfunction in 100,000 Patients

Scientific data-gathering effort will provide meaningful information on a cardiac condition that precedes or accompanies serious heart disease such as heart failure Indianapolis, Ind. and St....

Nov 13, 2002
Guidant and Genzyme Announce Cross-License Agreement

Deal Demonstrates Guidant's Commitment to Innovation and Intellectual Property Indianapolis, Ind. and Cambridge, Mass. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Nov 13, 2002
Guidant to Participate in the Credit Suisse First Boston Health Care Conference

Live Webcast Available Indianapolis, Ind - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...

Nov 8, 2002
Guidant to Host Mid-Quarter Investor Briefing

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host a...

Oct 30, 2002
Guidant Offers Award-Winning Women's Health Care Physician Education Program

Program Designed to Improve Prevention, Diagnosis and Treatment of Cardiovascular Disease in Women Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 25, 2002
Guidant Announces First Implants of Next Generation Heart Failure Technology

Live Broadcast of Implants Allows Physicians to Participate in Unique Training Opportunity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Oct 24, 2002
Guidant Submits Application for FDA Approval of MULTI-LINK VISION Cobalt Chromium Coronary Stent

Stent System Incorporates Innovative Material for Excellent Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 17, 2002
Guidant Reports All-Time Record Sales and Third Quarter Earnings

Quarterly Sales grew 25 percent to $827 million with Net Income of $175 million (+43 percent) and Earnings Per Share of $0.57 (+42 percent) Double-digit sales and earnings growth projected for...

Show per page

Top